These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 3570777)

  • 21. Stability of dithranol in creams.
    Wuis EW; Burger DM; Beelen M; Hekster YA
    Pharm World Sci; 1999 Dec; 21(6):275-7. PubMed ID: 10658238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of clobetasol-17-propionate and crude coal tar on dithranol-induced inflammation. A clinical and biochemical study.
    van de Kerkhof PC; Timmerman MG
    Acta Derm Venereol; 1990; 70(5):434-7. PubMed ID: 1980981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Psoriasis: the clinical use of "minute therapy" with Cignolin].
    Runne U; Kunze J
    Z Hautkr; 1983 Feb; 58(4):219-29. PubMed ID: 6845794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Treatment of psoriasis using Cignolin (dihydroxyanthranol): CSP (Cignolin-Salicylic acid-Petrolatum) - treatment schedule from Cologne].
    Orfanos CE; Steigleder GK
    Z Hautkr; 1976 Jun; 51(12):473-80. PubMed ID: 952029
    [No Abstract]   [Full Text] [Related]  

  • 25. [Dithranol-urea treatment of chronic psoriasis. A comparison of 0,1% dithranol + 17% urea with triamcinolone acetonite 0,1% and phototherapy (author's transl)].
    Ernst TM
    Z Hautkr; 1981 Sep; 56(18):1197-206. PubMed ID: 7293304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dithranol: further investigations on the structure-activity-relationship. The new series of the 10-mono-alkyldithranol derivatives.
    Schaltegger A; Brunner F; Steiger W; Krebs A
    Dermatologica; 1987; 175(3):136-41. PubMed ID: 3653461
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antipsoriatic activity of 10-acyl analogues of dithranol (anthralin). I. Phase I clinical trial of 10-propionyl dithranol and 10-butyryl dithranol (butantrone).
    Mustakallio KK; Brandt H
    Acta Derm Venereol; 1984; 64(1):63-6. PubMed ID: 6203285
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The oxidation behavior of dithranol].
    Schaltegger A
    Arzneimittelforschung; 1985; 35(4):666-8. PubMed ID: 4015731
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The in vivo fate of topically applied dithranol in the skin of the hairless rat. A comparison of continuous and short contact application.
    Cavey D; Dickinson RG; Shroot B; Schaefer H
    Arzneimittelforschung; 1985; 35(3):605-9. PubMed ID: 4039587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An investigation of the ability of antipsoriatic drugs to inhibit calmodulin activity: a possible mode of action of dithranol (anthralin).
    Tucker WF; MacNeil S; Dawson RA; Tomlinson S; Bleehen SS
    J Invest Dermatol; 1986 Aug; 87(2):232-5. PubMed ID: 3016102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The relevance of salicylic acid in the treatment of plaque psoriasis with dithranol creams.
    de Mare S; Calis N; den Hartog G; van Erp PE; van de Kerkhof PC
    Skin Pharmacol; 1988; 1(4):259-64. PubMed ID: 2483115
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Choice of 2 sequential topical antipsoriatic treatments].
    Colombi A; Tagliavini R
    Boll Chim Farm; 1972 May; 111(5):269-76. PubMed ID: 5050926
    [No Abstract]   [Full Text] [Related]  

  • 33. Skin irritation by dithranol cream. A blind study to assess the role of the cream formulation.
    Prins M; Swinkels OQ; Kolkman EG; Wuis EW; Hekster YA; van der Valk PG
    Acta Derm Venereol; 1998 Jul; 78(4):262-5. PubMed ID: 9689292
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dynamics of drug release from ointment bases. 2.: Packaging possibilities and effect of packaging on the release of salicylic acid from dimethyl sulfoxide-containing ointment bases].
    Lakowska J; Botev B; Trandafilov T
    Pharmazie; 1974 Jun; 29(6):420-1. PubMed ID: 4848533
    [No Abstract]   [Full Text] [Related]  

  • 35. In vitro release of anthralin from white petrolatum and an o/w cream.
    Kneczke M; Rahm C; Landersjö L; Lundgren P
    Acta Pharm Nord; 1989; 1(5):249-58. PubMed ID: 2610901
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of dithranol cream, 0.25% and 0.1%, and dithranol ointment 0.25% in the treatment of psoriasis.
    Fredriksson T
    Pharmatherapeutica; 1983; 3(7):496-8. PubMed ID: 6366807
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
    Thawornchaisit P; Harncharoen K
    J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dithranol allergy: fact or fiction?
    Burden AD; Stapleton M; Beck MH
    Contact Dermatitis; 1992 Nov; 27(5):291-3. PubMed ID: 1493682
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect on epidermal DNA synthesis of a combination of topical steroid with either dithranol or tar as used for psoriasis.
    Clement M; Hehir M; Phillips H; du Vivier A
    Br J Dermatol; 1983 Sep; 109(3):327-35. PubMed ID: 6615719
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Therapy of psoriasis].
    Pfister R
    Dtsch Med Wochenschr; 1970 Feb; 95(9):470-3. PubMed ID: 5308562
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.